Search Results 1491-1500 of 18139 for monoclonal antibody
... antibody. Convalescent plasma (CCP) or anti-SARS-CoV-2 monoclonal antibodies administered less than 24 hours prior to randomization. Patient must have ...
... antibody) * Olaparib (a type of PARP inhibitor). Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young. Rochester, Minn. The aim of this ...
Known severe hypersensitivity reactions to monoclonal antibodies (Grade ≥ 3 NCI-CTC), any history of anaphylaxis, or uncontrolled asthma. Any known allergy ...
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
Note: Subjects with antibodies to HBsAg ... Hypersensitivity: Subjects with a known allergy or intolerance to a monoclonal antibody or biologic therapy.
Treatment with any monoclonal antibody within 4 weeks of screening; History or evidence of colonic mucosal dysplasia; HIV, hepatitis B, hepatitis C, or ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
... antibody) * Olaparib (a type of PARP inhibitor). Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System Tumors.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.